Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, Optical Coherence | 14 | 2024 | 214 | 2.920 |
Why?
|
| Intracranial Aneurysm | 12 | 2024 | 351 | 2.900 |
Why?
|
| Stents | 7 | 2024 | 468 | 1.570 |
Why?
|
| Disease Models, Animal | 8 | 2024 | 2060 | 1.370 |
Why?
|
| Self Expandable Metallic Stents | 5 | 2020 | 33 | 1.150 |
Why?
|
| Rabbits | 10 | 2024 | 326 | 1.110 |
Why?
|
| Thrombosis | 5 | 2020 | 188 | 1.100 |
Why?
|
| Phosphorylcholine | 2 | 2024 | 42 | 1.010 |
Why?
|
| Endovascular Procedures | 8 | 2024 | 621 | 0.910 |
Why?
|
| Embolization, Therapeutic | 6 | 2020 | 310 | 0.880 |
Why?
|
| Heparin | 1 | 2024 | 111 | 0.840 |
Why?
|
| Peroxidase | 1 | 2023 | 70 | 0.820 |
Why?
|
| Vascular Remodeling | 1 | 2020 | 24 | 0.690 |
Why?
|
| Animals | 28 | 2024 | 19702 | 0.680 |
Why?
|
| Aneurysm | 1 | 2020 | 57 | 0.670 |
Why?
|
| Aspirin | 2 | 2020 | 167 | 0.660 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 170 | 0.640 |
Why?
|
| Stroke | 7 | 2023 | 1134 | 0.600 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2020 | 211 | 0.590 |
Why?
|
| Dogs | 8 | 2024 | 316 | 0.570 |
Why?
|
| Brain Ischemia | 4 | 2022 | 402 | 0.510 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2024 | 2064 | 0.460 |
Why?
|
| Thrombectomy | 7 | 2023 | 214 | 0.460 |
Why?
|
| Infarction, Middle Cerebral Artery | 3 | 2019 | 70 | 0.450 |
Why?
|
| Catheters | 5 | 2020 | 74 | 0.420 |
Why?
|
| Cerebral Angiography | 4 | 2023 | 282 | 0.390 |
Why?
|
| Basilar Artery | 2 | 2024 | 31 | 0.390 |
Why?
|
| Angiography, Digital Subtraction | 3 | 2024 | 133 | 0.390 |
Why?
|
| Cerebral Arteries | 2 | 2024 | 40 | 0.390 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2024 | 137 | 0.380 |
Why?
|
| Models, Anatomic | 3 | 2023 | 63 | 0.370 |
Why?
|
| Treatment Outcome | 11 | 2024 | 5333 | 0.350 |
Why?
|
| Phantoms, Imaging | 2 | 2024 | 217 | 0.330 |
Why?
|
| Neointima | 2 | 2018 | 19 | 0.300 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2018 | 218 | 0.270 |
Why?
|
| Swine | 3 | 2024 | 360 | 0.250 |
Why?
|
| Inflammation | 2 | 2023 | 1101 | 0.240 |
Why?
|
| Surface Properties | 2 | 2024 | 272 | 0.240 |
Why?
|
| Random Allocation | 3 | 2020 | 190 | 0.240 |
Why?
|
| RNA, Small Interfering | 2 | 2021 | 860 | 0.230 |
Why?
|
| Contrast Media | 2 | 2024 | 408 | 0.220 |
Why?
|
| Carotid Artery, Common | 1 | 2024 | 31 | 0.220 |
Why?
|
| Central Nervous System | 3 | 2024 | 194 | 0.220 |
Why?
|
| Thromboembolism | 1 | 2024 | 70 | 0.220 |
Why?
|
| Microscopy | 2 | 2024 | 91 | 0.220 |
Why?
|
| Drug-Eluting Stents | 1 | 2024 | 53 | 0.220 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2023 | 278 | 0.210 |
Why?
|
| Wound Healing | 1 | 2024 | 179 | 0.200 |
Why?
|
| Iron | 1 | 2023 | 136 | 0.200 |
Why?
|
| Oxidation-Reduction | 1 | 2023 | 304 | 0.200 |
Why?
|
| Neurosurgical Procedures | 1 | 2023 | 96 | 0.190 |
Why?
|
| Subarachnoid Space | 1 | 2022 | 10 | 0.190 |
Why?
|
| Intracranial Embolism | 1 | 2021 | 39 | 0.180 |
Why?
|
| Embolism | 1 | 2021 | 39 | 0.180 |
Why?
|
| Male | 9 | 2024 | 27948 | 0.180 |
Why?
|
| C9orf72 Protein | 1 | 2021 | 104 | 0.180 |
Why?
|
| Phenotype | 1 | 2024 | 1142 | 0.180 |
Why?
|
| Vertebral Artery | 1 | 2020 | 27 | 0.170 |
Why?
|
| Carotid Arteries | 1 | 2020 | 62 | 0.170 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2020 | 44 | 0.160 |
Why?
|
| Cisterna Magna | 1 | 2019 | 15 | 0.160 |
Why?
|
| Device Removal | 1 | 2020 | 65 | 0.160 |
Why?
|
| Cryotherapy | 1 | 2019 | 13 | 0.160 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 36 | 0.160 |
Why?
|
| Biomechanical Phenomena | 1 | 2020 | 242 | 0.160 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2020 | 653 | 0.160 |
Why?
|
| Hemodynamics | 1 | 2020 | 231 | 0.160 |
Why?
|
| Neuronavigation | 1 | 2018 | 13 | 0.150 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 604 | 0.150 |
Why?
|
| Huntingtin Protein | 1 | 2019 | 138 | 0.150 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2017 | 70 | 0.150 |
Why?
|
| Acute Disease | 1 | 2020 | 660 | 0.150 |
Why?
|
| Forecasting | 1 | 2019 | 223 | 0.150 |
Why?
|
| Transduction, Genetic | 1 | 2019 | 228 | 0.150 |
Why?
|
| Genetic Therapy | 2 | 2021 | 735 | 0.140 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 305 | 0.140 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2017 | 23 | 0.140 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2017 | 39 | 0.130 |
Why?
|
| Gene Expression | 1 | 2019 | 811 | 0.130 |
Why?
|
| Mutation | 2 | 2021 | 2462 | 0.130 |
Why?
|
| Blood Vessels | 1 | 2015 | 62 | 0.120 |
Why?
|
| Humans | 17 | 2024 | 59736 | 0.120 |
Why?
|
| Female | 7 | 2020 | 30921 | 0.110 |
Why?
|
| Genetic Vectors | 1 | 2019 | 809 | 0.110 |
Why?
|
| Dependovirus | 1 | 2019 | 653 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1555 | 0.100 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2015 | 302 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 791 | 0.090 |
Why?
|
| Carotid Artery, Internal | 2 | 2023 | 67 | 0.090 |
Why?
|
| Sheep | 2 | 2021 | 172 | 0.090 |
Why?
|
| Time Factors | 1 | 2017 | 3629 | 0.080 |
Why?
|
| Pancreatic Elastase | 2 | 2020 | 32 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2023 | 6152 | 0.080 |
Why?
|
| Hyperplasia | 2 | 2018 | 85 | 0.070 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2019 | 55 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 2 | 2020 | 175 | 0.060 |
Why?
|
| Ethiodized Oil | 1 | 2024 | 7 | 0.060 |
Why?
|
| Enbucrilate | 1 | 2024 | 9 | 0.060 |
Why?
|
| Phosphorothioate Oligonucleotides | 1 | 2024 | 10 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2024 | 1540 | 0.060 |
Why?
|
| Miniaturization | 1 | 2024 | 10 | 0.060 |
Why?
|
| Mice | 3 | 2024 | 10316 | 0.060 |
Why?
|
| Computed Tomography Angiography | 1 | 2023 | 113 | 0.050 |
Why?
|
| Intravital Microscopy | 1 | 2022 | 12 | 0.050 |
Why?
|
| Infarction | 1 | 2022 | 20 | 0.050 |
Why?
|
| Drug Administration Routes | 1 | 2021 | 20 | 0.050 |
Why?
|
| Motor Activity | 1 | 2024 | 333 | 0.050 |
Why?
|
| Microsurgery | 1 | 2022 | 51 | 0.050 |
Why?
|
| Brain | 2 | 2019 | 1495 | 0.040 |
Why?
|
| Oxygen | 1 | 2022 | 315 | 0.040 |
Why?
|
| Arteries | 1 | 2020 | 77 | 0.040 |
Why?
|
| Angiography | 1 | 2020 | 145 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2020 | 63 | 0.040 |
Why?
|
| Cadaver | 1 | 2020 | 114 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2021 | 378 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2019 | 44 | 0.040 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2020 | 125 | 0.040 |
Why?
|
| Lung | 1 | 2024 | 926 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 357 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2020 | 212 | 0.040 |
Why?
|
| Hypothermia, Induced | 1 | 2019 | 40 | 0.040 |
Why?
|
| Cerebral Revascularization | 1 | 2019 | 30 | 0.040 |
Why?
|
| Video Recording | 1 | 2019 | 129 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2019 | 243 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2020 | 163 | 0.040 |
Why?
|
| Transgenes | 1 | 2019 | 177 | 0.040 |
Why?
|
| Models, Animal | 1 | 2019 | 224 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 145 | 0.040 |
Why?
|
| Middle Cerebral Artery | 1 | 2019 | 46 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 75 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 1207 | 0.040 |
Why?
|
| Cattle | 1 | 2019 | 304 | 0.040 |
Why?
|
| Catheterization | 1 | 2018 | 111 | 0.040 |
Why?
|
| Phosphorus | 1 | 2017 | 16 | 0.040 |
Why?
|
| Choline | 1 | 2017 | 20 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2018 | 110 | 0.030 |
Why?
|
| Angioplasty | 1 | 2017 | 51 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 679 | 0.030 |
Why?
|
| Neurons | 1 | 2021 | 865 | 0.030 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2018 | 160 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1126 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2015 | 228 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2019 | 1472 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2354 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 1570 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 2011 | 57 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2011 | 476 | 0.020 |
Why?
|
| Algorithms | 1 | 2015 | 981 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 5011 | 0.020 |
Why?
|
| Middle Aged | 1 | 2018 | 16452 | 0.010 |
Why?
|